NCT01369563View on ClinicalTrials.gov

Efficacy, Safety & Tolerability of Ciclesonide 200mcg Spray 4 Weeks Treatment for Intermittent & Persistent Rhinitis

CompletedOBSERVATIONAL
Enrollment

1,630

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Perennial RhinitisSeasonal Rhinitis
Trial Locations (1)

53519

Yasmín Crespo, Naucalpan

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY